Ardelyx (ARDX) Net Margin Growth (1y) (2014 - 2026)

Ardelyx (ARDX) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 1,571.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,571.00
Dec 31, 2025 -432.00
Sep 30, 2025 -2,768.00
Jun 30, 2025 294.00
Mar 31, 2025 210.00
Dec 31, 2024 8,782.00
Sep 30, 2024 -1,258.00
Jun 30, 2024 5,419.00
Mar 31, 2024 17,787.00
Dec 31, 2023 -10,803.00
Sep 30, 2023 47,090.00
Jun 30, 2023 98,977.00
Mar 31, 2023 576,259.00
Dec 31, 2022 354,549.00
Sep 30, 2022 325,671.00
Jun 30, 2022 237,523.00
Mar 31, 2022 -549,435.00
Dec 31, 2021 -192,504.00
Sep 30, 2021 -304,840.00
Jun 30, 2021 -208,240.00